Picture of Zepp Health logo

ZEPP — Zepp Health News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologySpeculativeMicro CapContrarian

Smart wearables firm Zepp Health's Q2 revenue rises on new product launches

Smart wearables firm Zepp Health's Q2 revenue rises on new product launches


Overview

  • The smart wearables firm's Q2 revenue rose 6.9% yr/yr, driven by new product launches

  • Net loss widened as higher revenue and margin gains offset by FX headwinds, higher R&D and marketing

  • Gross margin improved to 37.4% on favorable product mix, partly offset by higher component costs


Outlook

  • Zepp Health expects Q3 2026 net revenues between $68 mln and $73 mln

  • Company says improved product mix and demand will not be fully reflected in Q3 revenue due to supply and production cycles

  • Zepp Health expects overall expense levels to decline as new product launch pace moderates


Result Drivers

  • NEW PRODUCT LAUNCHES - Co said Q2 sales growth was mainly driven by launches of Active 3 Premium, Active Max, and Cheetah models

  • PRODUCT MIX SHIFT - Gross margin improvement was attributed to a more favorable product mix and higher-value products, per CFO Leon Deng

  • SUPPLY CONSTRAINTS - Co said supply issues limited financial contribution from Bip and Helio Strap product families during Q2


Company press release: ID:nPn9ht6nMa


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Gross Margin

37.40%


Analyst Coverage

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the phones & handheld devices peer group is "buy."

  • Wall Street's median 12-month price target for Zepp Health Corp is $61.83, about 1,274% above its September 1 closing price of $4.50


Reuters Recommended Reads

  • Aug 31 - China's Ingdan interim revenue rises on AI chip demand

  • Aug 31 - China's Zhipu AI revenue quintuples in first half, loss narrows


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Zepp Health

See all news